Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

DTC Risk Disclosures Examined By FDA; Do Minor Risks Swamp Major Ones?

Mar 19 2007

• By Brian Marson

Related Content

Risk Information “Window” Proposed By FDA For DTC Print Ads

Feb 09 2004

FDA DTC Study Should Use Real Ads, Be More Conversational – AstraZeneca

May 02 2005

AstraZeneca Takes Five: DTC Study Finds Five Risks Per Ad Is Optimal For Recall

May 15 2006

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window